late-stage ovarian cancer

June 26, 2019

FDA Grants Priority Review to GSK’s Zejula for Late Stage Ovarian Cancer

News

The U.S. Food and Drug Administration (FDA) has accepted the application of Tesaro, a GSK company, seeking to extend approval for Zejula (niraparib) to women with late stage ovarian cancer ... Read more

February 21, 2018February 21, 2018

Innovation’s Kevetrin Shows Promising Results in Trial for Late-stage Ovarian Cancer

News

A Phase 2a trial testing Innovation Pharmaceuticals’ p53 modulator Kevetrin as a treatment for late-stage ovarian cancer has been completed, the company announced. The study showed positive anti-cancer results, supporting the development of an ... Read more